The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspbeta57 MHC class II molecules.

Quarsten H, Paulsen G, Johansen BH, Thorpe CJ, Holm A, Buus S, Sollid LM.

Int Immunol, 1998

doi:10.1093/intimm/10.8.1229.

Anti-Fas IgG1 antibodies recognizing the same epitope of Fas/APO-1 mediate different biological effects in vitro.

Fadeel B, Thorpe CJ, Yonehara S, Chiodi F.

Int Immunol, 1997

doi:10.1093/intimm/9.2.201.

Major histocompatibility complex and T cell receptor interaction of the P91A tum- peptide.

McCormick D, Stauss HJ, Thorpe C, Travers P, Dyson PJ.

Eur J Immunol, 1996

doi:10.1002/eji.1830261214.

Both alpha and beta chain polymorphisms determine the specificity of the disease-associated HLA-DQ2 molecules, with beta chain residues being most influential.

Johansen BH, Jensen T, Thorpe CJ, Vartdal F, Thorsby E, Sollid LM.

Immunogenetics, 1996

doi:10.1007/s002510050182.

The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule.

Vartdal F, Johansen BH, Friede T, Thorpe CJ, Stevanović S, Eriksen JE, Sletten K, Thorsby E, Rammensee HG, Sollid LM.

Eur J Immunol, 1996

doi:10.1002/eji.1830261132.

Shared fine specificity between T-cell receptors and an antibody recognizing a peptide/major histocompatibility class I complex.

Stryhn A, Andersen PS, Pedersen LO, Svejgaard A, Holm A, Thorpe CJ, Fugger L, Buus S, Engberg J.

Proc Natl Acad Sci U S A, 1996

doi:10.1073/pnas.93.19.10338.

Immunization with glycosylated Kb-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells.

Abdel-Motal UM, Berg L, Rosén A, Bengtsson M, Thorpe CJ, Kihlberg J, Dahmén J, Magnusson G, Karlsson KA, Jondal M.

Eur J Immunol, 1996

doi:10.1002/eji.1830260307.

An analysis of the antigen binding site of RT1.Aa suggests an allele-specific motif.

Thorpe CJ, Moss DS, Powis SJ, Howard JC, Butcher GW, Travers PJ.

Immunogenetics, 1995

doi:10.1007/bf00172160.

Altered MHC class I presented peptide repertoire is not sufficient to induce NK cell mediated F1-hybrid resistance.

Salcedo M, Höglund P, Achour A, Thorpe CJ, Ljunggren HG.

Mol Immunol, 1995

doi:10.1016/0161-5890(95)00048-j.

Mapping of the linear site on the Fas/APO-1 molecule targeted by the prototypic anti-Fas mAb.

Fadeel B, Thorpe J, Chiodi F.

Int Immunol, 1995

doi:10.1093/intimm/7.12.1967.

Similar antigenic surfaces, rather than sequence homology, dictate T-cell epitope molecular mimicry.

Quaratino S, Thorpe CJ, Travers PJ, Londei M.

Proc Natl Acad Sci U S A, 1995

doi:10.1073/pnas.92.22.10398.

Comparative modelling of major house dust mite allergen Der p I: structure validation using an extended environmental amino acid propensity table.

Topham CM, Srinivasan N, Thorpe CJ, Overington JP, Kalsheker NA.

Protein Eng, 1994

doi:10.1093/protein/7.7.869.

Prediction of an HLA-B44 binding motif by the alignment of known epitopes and molecular modeling of the antigen binding cleft.

Thorpe CJ, Travers PJ.

Immunogenetics, 1994

doi:10.1007/bf00189977.

Overlapping T-cell epitopes in the group I allergen of Dermatophagoides species restricted by HLA-DP and HLA-DR class II molecules.

Higgins JA, Thorpe CJ, Hayball JD, O'Hehir RE, Lamb JR.

J Allergy Clin Immunol, 1994

doi:10.1016/0091-6749(94)90383-2.

Clonal analysis of the atopic immune response to the group 2 allergen of Dermatophagoides spp.: identification of HLA-DR and -DQ restricted T cell epitopes.

Verhoef A, Higgins JA, Thorpe CJ, Marsh SG, Hayball JD, Lamb JR, O'Hehir RE.

Int Immunol, 1993

doi:10.1093/intimm/5.12.1589.

Outsize peptides bulge out of the groove.

Thorpe CJ.

Immunol Today, 1993

doi:10.1016/0167-5699(93)90057-r.

Anchored fore and aft.

Travers PJ, Thorpe CJ.

Curr Biol, 1992

doi:10.1016/0960-9822(92)90141-v.

Molecular modelling studies and the chromatographic behaviour of oxiracetam and some closely related molecules.

Camilleri P, Murphy JA, Saunders MR, Thorpe CJ.

J Comput Aided Mol Des, 1991

doi:10.1007/bf00126662.

Calmodulin discriminates between the two enantiomers of the receptor-operated calcium channel blocker SK&F 96365: a study using 1H-NMR and chiral HPLC.

Reid DG, MacLachlan LK, Robinson SP, Camilleri P, Dyke CA, Thorpe CJ.

Chirality, 1990

doi:10.1002/chir.530020407.